---
schema_version: "secwatch.filing_event.v1"
accession: "0001699031-25-000016"
form_type: "8-K"
ticker: "GRAL"
cik: "0001699031"
company_name: "GRAIL, Inc."
filed_at: "2025-02-20T23:59:59+00:00"
generated_at: "2026-05-26T09:00:25.187158+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# GRAIL Q4 rev $38.3M (+26%), net loss $97.1M; FY Galleri rev $108.6M (+45%); adds TRICARE coverage

## Summary
- Q4 total revenue $38.3M (+26% YoY); Q4 Galleri revenue $31.6M (+39% YoY).
- Full year 2024 total revenue $125.6M (+35% YoY); Galleri revenue $108.6M (+45% YoY).
- Q4 net loss $97.1M including $34.6M amortization; full year net loss $2.0B incl $1.4B goodwill impairment.
- Non-GAAP adjusted EBITDA: Q4 ($84.0M), full year ($483.5M); cash position $767M, runway into 2028.
- TRICARE added Galleri as covered benefit for 50+ patients; registrational studies completed, PMA submission planned H1 2026.

## SEC filing metadata
- accession: 0001699031-25-000016
- form_type: 8-K
- ticker: GRAL
- cik: 0001699031
- company_name: GRAIL, Inc.
- filed_at: 2025-02-20T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1699031/000169903125000016/0001699031-25-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1699031/000169903125000016/gral-20250220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001699031-25-000016
- JSON: https://secwatch.observer/filing/0001699031-25-000016.json
- Plain text: https://secwatch.observer/filing/0001699031-25-000016.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.